The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke

Nature Genetics

Volumn 36, Issue 3, 2004, Pages 233-239

  Helgadottir, Anna ^a   Manolescu, Andrei ^a   Thorleifsson, Gudmar ^a   Gretarsdottir, Solveig ^a   Jonsdottir, Helga ^a   Thorsteinsdottir, Unnur ^a   Samani, Nilesh J ^b   Gudmundsson, Gudmundur ^a   Grant, Struan F A ^a   Thorgeirsson, Gudmundur ^c   Sveinbjornsdottir, Sigurlaug ^c   Valdimarsson, Einar M ^c   Matthiasson, Stefan E ^c   Johannsson, Halldor ^c   Gudmundsdottir, Olof ^a   Gurney, Mark E ^a   Sainz, Jesus ^a   Thorhallsdottir, Margret ^a   Andresdottir, Margret ^a   Frigge, Michael L ^a   Topol, Eric J ^d   Kong, Augustine ^a   Gudnason, Vilmundur ^e   Hakonarson, Hakon ^a   Gulcher, Jeffrey R ^a   Stefansson, Kari ^a   more..

^a DECODE GENETICS   (Iceland)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^d LERNER RESEARCH INSTITUTE   (United States)

^e ICELANDIC HEART ASSOCIATION   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; LEUKOTRIENE B4;

ADULT; AGED; ARTERY WALL; ARTICLE; CHROMOSOME 13Q; CONTROLLED STUDY; FATTY ACID SYNTHESIS; FEMALE; GENE LOCUS; GENE MAPPING; GENETIC PREDISPOSITION; HAPLOTYPE; HEART INFARCTION; HUMAN; HUMAN CELL; ICELAND; INFLAMMATION; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE; UNITED KINGDOM;

CARRIER PROTEINS; CEREBROVASCULAR ACCIDENT; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 13; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKOTRIENE B4; MEMBRANE PROTEINS; MICROSATELLITE REPEATS; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 10744220794     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1311     Document Type: Article

References (50)

1. Bonow, R.O., Smaha, L.A., Smith, S.C. Jr., Mensah, G.A. & Lenfant, C. World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation 106, 1602-1605 (2002).
2. Heart Disease and Stroke Statistics, 2003 Update (American Heart Association, Dallas, Texas, 2002).
3. Lusis, A.J. Atherosclerosis. Nature 407, 233-241 (2000).
4. Libby, P. Inflammation in atherosclerosis. Nature 420, 868-874 (2002).
5. Stratford, N., Britten, K. & Gallagher, P. Inflammatory infiltrates in human coronary atherosclerosis. Atherosclerosis 59, 271-276 (1986).
6. Poole, J.C. & Florey, H.W. Changes in the endothelium of the aorta and the behaviour of macrophages in experimental atheroma of rabbits. J. Pathol. Bacteriol. 75, 245-251 (1958).
7. Topol, E.J. et al. Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation 104, 2641-2644 (2001).
8. Ozaki, K. et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat. Genet. 32, 650-654 (2002).
9. Yamada, Y. et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N. Engl. J. Med. 347, 1916-1923 (2002).
10. Broeckel, U. et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat. Genet. 30, 210-214 (2002).
11. Francke, S. et al. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum. Mol. Genet. 10, 2751-2765 (2001).
12. Harrap, S.B. et al. Genome-wide linkage analysis of the acute coronary syndrome suggests a locus on chromosome 2. Arterioscler. Thromb. Vasc. Biol. 22, 874-878 (2002).
13. Pajukanta, P. et al. Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am. J. Hum. Genet. 67, 1481-1493 (2000).
14. Wang, L., Fan, C., Topol, S.E., Topol, E.J. & Wang, Q. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 302, 1578-1581 (2003).
15. Dixon, R.A. et al. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 343, 282-284 (1990).
16. Mehrabian, M. et al. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ. Res. 91, 120-126 (2002).
17. Brezinski, D.A., Nesto, R.W. & Serhan, C.N. Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy. Circulation 86, 56-63 (1992).
18. Spanbroek, R. et al. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc. Natl. Acad. Sci. USA 100, 1238-1243 (2003).
19. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J. Clin. Epidemiol. 41, 105-14 (1988).
20. Koshino, T. et al. Novel polymorphism of the 5-lipoxygenase activating protein (FLAP) promoter gene associated with asthma. Mol. Cell. Biol. Res. Commun. 2, 32-35 (1999).
21. Sala, A., Bolla, M., Zarini, S., Muller-Peddinghaus, R. & Folco, G. Release of leukotriene A4 versus leukotriene B4 from human polymorphonuclear leukocytes. J. Biol. Chem. 271, 17944-17948 (1996).
22. Dahinden, C.A., Clancy, R.M., Gross, M., Chiller, J.M. & Hugli, T.E. Leukotriene C4 production by murine mast cells: evidence of a role for extracellular leukotriene A4. Proc. Natl. Acad. Sci. USA 82, 6632-6636 (1985).
23. Fiore, S. & Serhan, C.N. Formation of lipoxins and leukotrienes during receptor-mediated interactions of human platelets and recombinant human granulocyte/macrophage colony-stimulating factor-primed neutrophils. J. Exp. Med. 172, 1451-1457 (1990).
24. Ford-Hutchinson, A.W. Leukotriene B4 in inflammation. Crit. Rev. Immunol. 10, 1-12 (1990).
25. Samuelsson, B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220, 568-575 (1983).
26. Burke, J.A., Levi, R., Guo, Z.G. & Corey, E.J. Leukotrienes C4, D4 and E4: effects on human and guinea-pig cardiac preparations in vitro. J. Pharmacol. Exp. Ther. 221, 235-241 (1982).
27. Roth, D.M. & Lefer, A.M. Studies on the mechanism of leukotriene induced coronary artery constriction. Prostaglandins 26, 573-581 (1983).
28. Wargovich, T., Mehta, J., Nichols, W.W., Pepine, C.J. & Conti, C.R. Reduction in blood flow in normal and narrowed coronary arteries of dogs by leukotriene C4. J. Am. Coll. Cardiol. 6, 1047-1051 (1985).
29. Falk, E., Shah, P.K. & Fuster, V. Coronary plaque disruption. Circulation 92, 657-671 (1995).
30. Dwyer, J.H. et al. Arachidonate 5-Lipoxygenase Promoter Genotype, Dietary Arachidonic Acid, and Atherosclerosis. N. Engl. J. Med. 350, 29-37 (2004).
31. Aiello, R.J. et al. Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice. Arterioscler. Thromb. Vasc. Biol. 22, 443-449 (2002).
32. Gretarsdottir, S. et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat. Genet. 35, 131-138 (2003).
33. Gretarsdottir, S. et al. Localization of a susceptibility gene for common forms of stroke to 5q12. Am. J. Hum. Genet. 70, 593-603 (2002).
34. Gudmundsson, G. et al. Localization of a gene for peripheral arterial occlusive disease to chromosome 1p31. Am. J. Hum. Genet. 70, 586-592 (2002).
35. Gulcher, J.R., Kristjansson, K., Gudbjartsson, H. & Stefansson, K. Protection of privacy by third-party encryption in genetic research in Iceland. Eur. J. Hum. Genet. 8, 739-742 (2000).
36. Kong, A. & Cox, N.J. Allele-sharing models: LOD scores and accurate linkage tests. Am. J. Hum. Genet. 61, 1179-1188 (1997).
37. Gudbjartsson, D.F., Jonasson, K., Frigge, M.L. & Kong, A. Allegro, a new computer program for multipoint linkage analysis. Nat. Genet. 25, 12-13 (2000).
38. Kong, A. et al. A high-resolution recombination map of the human genome. Nat. Genet. 31, 241-247 (2002).
39. Whittemore, A.S. & Halpern, J. A class of tests for linkage using affected pedigree members. Biometrics 50, 118-127 (1994).
40. Kruglyak, L., Daly, M.J., Reeve-Daly, M.P. & Lander, E.S. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am. J. Hum. Genet. 58, 1347-1363 (1996).
41. Nicolae, D. Allele Sharing Models in Gene Mapping: A Likelihood Approach (University of Chicago, 1999).
42. Dempster, A., Laird, N.M. & Rubin, D.B. Maximum likelihood from incomplete data via the EM algorithm. J. R. Stat. Soc. B39, 1-38 (1977).
43. Terwilliger, J.D. & Ott, J. A haplotype-based 'haplotype relative risk' approach to detecting allelic associations. Hum. Hered. 42, 337-346 (1992).
44. Falk, C.T. & Rubinstein, P. Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann. Hum. Genet. 51 Pt 3, 227-233 (1987).
45. Lewontin, R.C. The interaction of selection and linkage. ii. Optimum models. Genetics 50, 757-782 (1964).
46. Hill, W.G. & Robertson, A. The effects of inbreeding at loci with heterozygote advantage. Genetics 60, 615-628 (1968).
47. Chen. X., Zehnbauer, B., Gnirke, A. & Kwok, P.Y. Fluorescence energy transfer detection as a homogeneous DNA diagnostic method. Proc. Natl. Acad. Sci. USA 94, 10756-10761 (1997).
48. Steeds, R., Adams, M., Smith, P., Channer, K. & Samani, N.J. Distribution of tissue plasminogen activator insertion/deletion polymorphism in myocardial infarction and control subjects. Thromb. Haemost. 79, 980-984 (1998).
49. Brouilette, S., Singh, R.K., Thompson, J.R., Goodall, A.H. & Samani, N.J. White cell telomere length and risk of premature myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 23, 842-846 (2003).
50. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 59, 607-609 (1979).